AdipoGenix Inc., of Boston, appointed Ed Cannon president and CEO.
Aegis Therapeutics Inc., of San Diego, appointed Cam Garner to its board.
Alexza Molecular Delivery Corp., of Palo Alto, Calif., appointed Daniel Spyker vice president of clinical and regulatory affairs.
Arysta LifeScience Corp., of Tokyo, appointed Donna Uchida global communications leader.
BioMedinvestor AG, of Basel, Switzerland, appointed Markus Hosang managing partner.
Cambridge Antibody Technology Group plc, of Cambridge, UK, said Patrick Round will oversee development activities and will join the executive group following the retirement of David Glover, the company's chief medical officer. Diane Mellett will join the board.
Cellegy Pharmaceuticals Inc., of South San Francisco, appointed Richard Williams interim CEO.
Cephalon Inc., of Malvern, Pa., said its chairman, CEO and founder, Frank Baldino, joined the board of Pennsylvania BIO.
CoTherix Inc., of South San Francisco, appointed David Gryska to its board, which he will serve as chairman of the audit committee.